Abstract
Within a decade after its first description, the multidrug-resistant yeast Candida auris has emerged globally as a nosocomial pathogen causing difficult to control outbreaks. This, together with the alarmingly high mortality rate of up to 66% associated with C. auris candidemia, calls for a better understanding of its virulence traits and routes of transmission. Unlike other clinically relevant Candida species, C. auris seems to have the unique ability to be easily transmitted between patients. Although initially thought to express fewer virulence traits than Candida albicans, recent genomic insights suggest C. auris to possess these traits to a much more similar extent. This review highlights the virulence traits C. auris expresses to attack the host, defend itself against antimicrobial agents and to persist within the healthcare environment.
| Original language | English |
|---|---|
| Pages (from-to) | 353-365 |
| Number of pages | 13 |
| Journal | Mycopathologia |
| Volume | 184 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - Jun 2019 |
Keywords
- Candida/drug effects
- Candidemia/epidemiology
- Communicable Diseases, Emerging/epidemiology
- Cross Infection/epidemiology
- Disease Outbreaks
- Disease Transmission, Infectious
- Drug Resistance, Multiple, Fungal
- Global Health
- Humans
- Virulence
- Virulence Factors/genetics